|
IM-MV 18-015_006
|
Erasmus MC
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A
|
26-05-2020
|
Vergunning verleend
|
|
IM-MV 18-017_004
|
Universitair Medisch Centrum Utrecht
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A
|
29-05-2020
|
Vergunning verleend
|
|
IM-MV 18-018_004
|
AMC
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Hemophilia A
|
05-06-2020
|
Vergunning verleend
|
|
IM-MV 18-020_004
|
UMCG
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A
|
26-05-2020
|
Vergunning verleend
|
|
IM-MV 20-002_000
|
Het Nederlands Kanker Instituut
|
Use of autologous patient-derived T cells enriched from peripheral blood mononuclear cells (PBMCs) and transduced with a gamma-retroviral self-inactivating (SIN) vector expressing a second generation chimeric antigen receptor (CAR) with specificity for the oncofetal antigen Claudin6 (CLDN6) under control of an internal promoter in patients suffering from CLDN6-positive malignancies
|
25-06-2020
|
Vergunning verleend
|
|
IM-MV 20-003_000
|
AMC
|
Clinical studies with MB‐CART2019.1, a product consisting of ex‐vivo lentiviral transduced T‐cells using a replication‐deficient lentiviral vector
|
17-06-2020
|
Vergunning verleend
|
|
IM-MV 20-004_000
|
UMCG
|
Clinical studies with MB-CART2019.1, a product consisting of ex-vivo lentiviral transduced T-cells using a replication-deficient lentiviral vector
|
|
Ontwerpbesluit genomen
|
|
IM-MV 20-005_000
|
Erasmus MC
|
Use of autologous patient-derived T cells enriched from peripheral blood mononuclear cells (PBMCs) and transduced with a gamma-retroviral self-inactivating (SIN) vector expressing a second generation chimeric antigen receptor (CAR) with specificity for the oncofetal antigen Claudin6 (CLDN6) under control of an internal promoter in patients suffering from CLDN6-positive malignancies
|
|
Ontwerpbesluit genomen
|
|
IM-MV 20-006_000
|
Erasmus MC
|
Clinical studies with MB-CART2019.1, a product consisting of ex-vivo lentiviral transduced T-cells using a replication-deficient lentiviral vector
|
|
Ontwerpbesluit genomen
|
